Abstract

Three dinuclear copper(II) complexes, [Cu2(L1)2(tp)]∙4H2O (1), [Cu2(L1)2(ppda)(H2O)2]∙2H2O (2) and [Cu2(L2)2(tp)(CH3OH)2]∙2H2O (3) (where HL1 = 2-methoxy-6-[(2-morpholin-4-yl-ethylimino)-methyl]-phenol, HL2 = 2-ethoxy-6-[(2-morpholin-4-yl-ethylimino)-methyl]-phenol, tp = terephthalate, ppda = p-phenylenediacrylate), have been synthesized and characterized by single crystal X-ray diffraction, FTIR, mass spectrometry and thermal analysis. All the complexes crystallize in the monoclinic system with the space group P21/n (for 1 and 2) and P21/c (for 3) as centrosymmetric species. In 1 and 3, two CuL1 and CuL2 units, respectively are bridged by a terephthalate (tp) anion, whereas in 2 the bridging unit is p-phenylenediacrylate (ppda). The copper atoms in 1 exhibit a square planar coordination geometry, while in 2 and 3 the metals have a square pyramidal environment. All of 1–3 form 1D supramolecular chains through C-H…π interaction. The interaction of the complexes with bovine serum albumin (BSA) was investigated using a fluorescence spectroscopic technique. The values of the binding constant are (15.9 ± 0.13) × 104 M−1 (for 1), (10.3 ± 0.08) × 104 M−1 (for 2) and (11.2 ± 0.37) × 104 M−1 (for 3). Using the Scatchard equation, the calculated values of the number of binding sites (n) are all around 1, signifying the presence of a single binding site in serum albumins for the Cu(II) complexes. The cytotoxicity of the complexes was tested using breast cancer MCF7 and MDA-MB-231 cells, along with normal breast epithelial MCF10A cells. MTT results reveal that the complexes potently suppressed the growth of the breast cancer cell lines MCF7 and MDA-MB-231, and the MCF10A cells. Complexes 1–3 inhibited fifty percent growth (IC50) at 5.80 ± 1.47, 20.85 ± 1.25 and 5.10 ± 1.23 μM for MCF7 cells, respectively. Treatment of complex 3 results in perturbation of the microtubule organization, which might be through attenuation of the tubulin level.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.